|Last Price$138.04||Day Change (%)0.03%|
|Open Price$137.90||Day Change ($)0.04|
|Day Range137.64–138.92||52-Week Range116.51–141.61|
As of Thu 3/23/2017 7:30:00 PM | USD
Alkermes Initiates Phase 3 Gastrointestinal Tolerability Study of ALKS 8700 for Treatment of Multiple Sclerosis
As mid-cap funds go, this one is an odd duck, but it earns top marks.
An ultralow fee gives this fund a sustainable edge relative to category peers.
Strong past performance alone doesn't justify a dedicated mid-cap fund.
We skinny down the number of holdings for this mid-50s couple who wants to make sure their ample portfolio is on the right track.
While this isn’t the only ETF that tracks the S&P MidCap 400 Index, a structural advantage gives this fund an edge.
For investors looking to build a portfolio based on rock-bottom fees, here's a list of funds and ETFs that can serve as building blocks.